Page last updated: 2024-08-25

rosiglitazone and gkt137831

rosiglitazone has been researched along with gkt137831 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Green, DE; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Page, P; Sutliff, RL; Szyndralewiez, C1

Other Studies

1 other study(ies) available for rosiglitazone and gkt137831

ArticleYear
The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.
    American journal of respiratory cell and molecular biology, 2012, Volume: 47, Issue:5

    Topics: Animals; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Gene Expression; Gene Knockdown Techniques; Humans; Hydrogen Peroxide; Hypertension, Pulmonary; Lung; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; NADPH Oxidase 4; NADPH Oxidases; PPAR gamma; Proliferating Cell Nuclear Antigen; Pulmonary Artery; Pyrazoles; Pyrazolones; Pyridines; Pyridones; RNA Interference; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta1; Ventricular Remodeling

2012